Apollo Hospitals Enterprise Ltd. Upgraded to Strong Buy on Robust Financials and Technical Momentum

Quality Assessment: Sustained Operational Excellence and Management Efficiency

Apollo Hospitals continues to showcase exceptional operational quality, underpinned by a high Return on Capital Employed (ROCE) of 17.13% for the latest fiscal year and an even stronger half-year ROCE of 17.41%. This metric highlights the company’s efficient use of capital to generate profits, a key indicator of management effectiveness. The hospital chain has reported positive results for 11 consecutive quarters, signalling consistent execution and resilience in a competitive healthcare sector.

Net sales have grown at an annualised rate of 16.82%, while operating profit has expanded even faster at 23.85%, reflecting strong margin improvement and operational leverage. The company’s net profit growth of 10.31% in the recent quarter further confirms its ability to convert revenue growth into bottom-line gains. Apollo’s operating profit to interest coverage ratio stands at a robust 9.07 times, indicating a comfortable buffer against financial costs and a solid balance sheet position.

These quality parameters place Apollo Hospitals among the top 1% of all 4,000 stocks rated by MarketsMojo, with a Mojo Score of 84.0 and a Mojo Grade upgrade from Buy to Strong Buy. The company ranks third among large caps and 24th across the entire market, underscoring its leadership in both quality and scale.

Valuation: Attractive Pricing Relative to Peers and Growth Prospects

Apollo Hospitals’ valuation metrics have improved, supporting the upgrade. The company’s Enterprise Value to Capital Employed ratio stands at a compelling 8.5, signalling that the stock is trading at a discount compared to its peers’ historical averages. This valuation is particularly attractive given Apollo’s strong growth trajectory and market leadership.

Over the past year, the stock has delivered a 13.10% return, outperforming the BSE500 index and generating a profit increase of 33.7%. The Price/Earnings to Growth (PEG) ratio of 1.8 suggests that the stock’s price reasonably reflects its earnings growth potential, making it a favourable pick for investors seeking growth at a fair price.

With a market capitalisation of ₹1,27,652 crores, Apollo Hospitals is the largest company in the hospital sector, representing 16.52% of the sector’s total market cap. Its annual sales of ₹26,429.90 crores account for nearly a quarter (24.58%) of the industry’s revenue, reinforcing its dominant position and pricing power.

Financial Trend: Strong Quarterly Performance and Consistent Growth

The recent quarterly results for Q1 FY26-27 were very positive, with net sales reaching a record ₹7,043.50 crores. Operating profit margins expanded, and net profit growth of 10.31% was reported, continuing a streak of 11 consecutive quarters of positive earnings. This consistent performance highlights the company’s ability to navigate sector challenges and capitalise on growth opportunities.

Institutional investors hold a significant 65.44% stake in Apollo Hospitals, reflecting strong confidence from sophisticated market participants who typically conduct rigorous fundamental analysis. This high institutional ownership often correlates with stock stability and informed price discovery.

Long-term returns have been impressive, with Apollo generating 82.70% returns over three years and an extraordinary 554.89% over ten years, vastly outperforming the Sensex’s 19.68% and 178.98% returns respectively over the same periods. This track record of consistent outperformance further validates the company’s financial strength and growth prospects.

Technical Outlook: Bullish Momentum Drives Upgrade

The upgrade to Strong Buy was significantly influenced by improvements in technical indicators. The technical trend has shifted from mildly bullish to bullish, signalling stronger momentum in the stock price. Key technical metrics include:

• MACD: Weekly remains mildly bearish but monthly is bullish, indicating longer-term upward momentum.
• RSI: Both weekly and monthly show no extreme signals, suggesting room for further price appreciation without overbought conditions.
• Bollinger Bands: Weekly readings are bullish, with monthly mildly bullish, reflecting positive price volatility and trend strength.
• Moving Averages: Daily moving averages are bullish, supporting near-term upward price movement.
• KST: Weekly mildly bearish but monthly bullish, aligning with the MACD’s mixed signals but overall positive monthly trend.
• Dow Theory: Weekly mildly bullish and monthly bullish, reinforcing the positive technical outlook.
• On-Balance Volume (OBV): Weekly shows no trend, but monthly is mildly bullish, indicating accumulation over the longer term.

On 26 Aug 2026, Apollo Hospitals closed at ₹8,878, up 2.05% from the previous close of ₹8,700. The stock’s 52-week high stands at ₹9,326.80, with a low of ₹6,680.00, reflecting a strong recovery and upward momentum. Daily trading ranges between ₹8,640 and ₹8,878 further demonstrate price resilience.

Comparative Performance: Outperforming Benchmarks and Sector Peers

Apollo Hospitals has consistently outperformed the Sensex and sector benchmarks across multiple time horizons. Year-to-date, the stock has surged 26.06%, while the Sensex has declined by 8.88%. Over the last one year, Apollo delivered a 13.10% return compared to the Sensex’s negative 4.88%. Its three-year return of 82.70% far exceeds the Sensex’s 19.68%, and the ten-year return of 554.89% dwarfs the Sensex’s 178.98%.

This sustained outperformance is a testament to the company’s strong fundamentals, strategic positioning, and effective capital allocation. As the largest player in the hospital sector, Apollo commands a 16.52% share of the sector’s market capitalisation and generates nearly a quarter of the industry’s sales, reinforcing its competitive moat.

Conclusion: Strong Buy Rating Reflects Comprehensive Strength

The upgrade of Apollo Hospitals Enterprise Ltd. to a Strong Buy rating by MarketsMojo is well justified by its superior quality metrics, attractive valuation, positive financial trends, and bullish technical signals. The company’s consistent quarterly growth, high management efficiency, and dominant market position provide a solid foundation for future appreciation.

Investors seeking exposure to the hospital and healthcare services sector would find Apollo Hospitals a compelling choice, given its proven track record, strong institutional backing, and favourable risk-reward profile. The technical momentum further supports the potential for near-term gains, making this upgrade a timely endorsement for both long-term and tactical investors.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today